Masafumi Tanaka

Dr. Masafumi Tanaka

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 November 2015 in Langmuir
Verified
Journal Article
Closed access
MTMasafumi Tanaka
Masafumi Tanaka
AHAkira Hosotani
Akira Hosotani
YTYuka Tachibana
Yuka Tachibana
MNMinoru Nakano
Minoru Nakano
KIKenji Iwasaki
Kenji Iwasaki
TMTakahiro Mukai
Takahiro Mukai

1 January 2011 in Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
Verified
Journal Article
Closed access
MTMasafumi Tanaka
Masafumi Tanaka
PDPadmaja Dhanasekaran
Padmaja Dhanasekaran
DNDavid Nguyen
David Nguyen
MNMargaret Nickel
Margaret Nickel
YTYuki Takechi
Yuki Takechi
HSHiroyuki Saito
Hiroyuki Saito

1 January 2014 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
HTHiroka Takase
Hiroka Takase
MTMasafumi Tanaka
Masafumi Tanaka
SMSachiko Miyagawa
Sachiko Miyagawa
TYToshiyuki Yamada
Toshiyuki Yamada
TMTakahiro Mukai
Takahiro Mukai

2 April 2016 in Amyloid
Verified
Journal Article
Closed access
PDF file
HTHiroka Takase
Hiroka Takase
MTMasafumi Tanaka
Masafumi Tanaka
AYAki Yamamoto
Aki Yamamoto
SWShiori Watanabe
Shiori Watanabe
STSanae Takahashi
Sanae Takahashi
TMTakahiro Mukai
Takahiro Mukai
Serum amyloid A (SAA) is a precursor protein of amyloid fibrils. Given that heparan sulfate (HS), a glycosaminoglycan (GAG), is detected in amyloid deposits, it has been suggested that GAG is a key component of amyloid fibril formation. We previously reported that heparin (an analog of HS) facilitates the fibril formation of SAA, but the structural requirements remain unknown. In the present study, we investigated the structural requirements of GAGs for facilitating the amyloid fibril formation of SAA. Spectroscopic analyses using structurally diverse GAG analogs suggested that the fibril formation of SAA was facilitated irrespective of the backbone structure of GAGs; however, the facilitating effect was strongly correlated with the degree of sulfation. Microscopic analyses revealed that the morphologies of SAA aggregates were modulated by the GAGs. The HS molecule, which is less sulfated than heparin but contains highly sulfated domains, exhibited a relatively high potential to facilitate fibril formation compared to other GAGs. The length dependence of fragmented heparins on the facilitating effect suggested that a high density of sulfate groups is also required. These results indicate that not only the degree of sulfation but also the lengths of sulfated domains in GAG play important roles in fibril formation of SAA.

7 August 2009 in Chemistry and Physics of Lipids
Verified
Journal Article
Closed access
SOShinya Ohta
Shinya Ohta
MTMasafumi Tanaka
Masafumi Tanaka
KSKota Sakakura
Kota Sakakura
TKToru Kawakami
Toru Kawakami
SASaburo Aimoto
Saburo Aimoto
HSHiroyuki Saito
Hiroyuki Saito

1 January 2017 in Chemistry and Physics of Lipids
Verified
Journal Article
Closed access
MTMasafumi Tanaka
Masafumi Tanaka
ANAyaka Nishimura
Ayaka Nishimura
HTHaruka Takeshita
Haruka Takeshita
HTHiroka Takase
Hiroka Takase
TYToshiyuki Yamada
Toshiyuki Yamada
TMTakahiro Mukai
Takahiro Mukai